No wonder Brits worry more about MRSA than waiting lists

Scientists say they believe as many as 53 million people may carry the superbug MRSA.

MRSA (Methicillin-Resistant Staphylococcus Aureus) is a nightmare for hospitals and nursing homes as it usually occurs in patients with weakened immune systems.

The scientists from the National Institute for Public Health and the Environment in the Netherlands, say the prevalence of the infection makes it the most commonly identified antibiotic-resistant pathogen in many parts of the world.

The superbug is a potential killer as it is resistant to certain antibiotics and can be spread by poor hygiene.

Scientists suggest that as many as 25-30 percent of the world's population now have a form of the bacteria Staphylococcus Aureus.

MRSA is found on a regular basis in Europe, north and south America, north Africa, the Middle East, and east Asia.

Professor Hajo Grundmann, scientific co-ordinator of the European Antimicrobial Resistance Surveillance System (EARSS) says that even in countries such as the Netherlands, Sweden and Norway, where incidents of MRSA have been historically low, the rates are rising.

Grundmann, one of the authors of the study, says genetic changes in the superbug could well make it even more resistant to treatment and more virulent.

He says the onus is on health-care authorities to develop surveillance systems and provide the resources for early recognition of MRSA carriers through rapid screening.

Grundmann says hospital staff have a responsibility to implement, maintain, and adhere to strict contact precautions, and hospitals must remain places where citizens can confidently expect positive health-care outcomes.

MRSA has been an increasing problem in many countries in recent years and a survey recently revealed that UK patients were far more worried about catching MRSA than about delays in treatment.

According to the Office for National Statistics the number of deaths linked to MRSA jumped 22% between 2003 and 2004 in the UK; the superbug kills between 5,000 and 20,000 patients every year in the UK.

The research is published in the current issue of The Lancet.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
N95 respirators potential standard of care in nursing homes and healthcare settings during respiratory viral infections